样式: 排序: IF: - GO 导出 标记为已读
-
Is micronized vaginal progesterone effective for the prevention of preeclampsia in twin pregnancies? Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-16 Odai Yaghi MBBS MD, Smriti Prasad MD, Holly Boorman MBBS, Erkan Kalafat MD, Asma Khalil MBBCH MD FRCOG
-
Perinatal outcomes of pregnancies following autologous cryopreserved ovarian tissue transplantation: a systematic review with pooled analysis Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-15 Murat Erden MD, Esra Uyanik MD, Isabelle Demeestere MD PhD, Kutluk H. Oktay MD PhD
This study aimed to synthesize the existing evidence on perinatal outcomes after autologous cryopreserved ovarian tissue transplantation, concurrently identifying key factors influencing these outcomes. A comprehensive search was performed on MEDLINE, Embase, and Cochrane Library databases to identify relevant studies on the effect of autologous cryopreserved ovarian tissue transplantation on perinatal
-
Executive summary: Workshop on maternal mental health, February 11–12, 2024, co-sponsored by the American College of Obstetricians and Gynecologists Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-10 Society for Maternal-Fetal Medicine
-
Metronidazole and cefazolin vs cefazolin alone for surgical site infection prophylaxis in gynecologic surgery at a comprehensive cancer center Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-08 Anne Knisely MD, Maria D. Iniesta MD PhD, Claire A. Marten PharmD, Gary Chisholm MS, Kathleen M. Schmeler MD, Jolyn S. Taylor MD
Surgical site infection is one of the most common complications of gynecologic cancer surgery. Current guidelines recommend the administration of cefazolin preoperatively to reduce surgical site infection rates for patients undergoing clean-contaminated surgeries such as hysterectomy. To evaluate the impact of a quality improvement project adding metronidazole to cefazolin for antibiotic prophylaxis
-
Spontaneous miscarriage and social support in predicting risks of depression and anxiety: a cohort study in UK Biobank Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-07 Ying Hu MD PhD, Rui Tang MS, Xiang Li MD PhD, Xuan Wang MD PhD, Hao Ma MD PhD, Yoriko Heianza PhD RD, Lu Qi MD PhD, Zhaoxia Liang MD PhD
It is still unclear whether social support can moderate the high risk of depression and anxiety due to spontaneous miscarriage. This study prospectively investigated the associations of spontaneous miscarriage with risks of depression and anxiety, and evaluated the interactions between spontaneous miscarriage and the degree of social support in relation to depression and anxiety risks. A total of 179
-
Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-07 Hiba J. Mustafa MD, Enaja V. Sambatur MD, Giorgio Pagani MD, Francesco D’Antonio MD, Emeline Maisonneuve MD, Paul Maurice MD, Carolien Zwiers MD, Joanne E.J.T. Verweij MD, Anna Flood BS, Alireza A. Shamshirsaz MD, Jean-Marie Jouannic MD, Asma Khalil MD
This study aimed to investigate the outcomes associated with the administration of maternal intravenous immunoglobulin in high-risk red blood cell–alloimmunized pregnancies. Medline, Embase, and Cochrane Library were systematically searched until June 2023. This review included studies reporting on pregnancies with severe red blood cell alloimmunization, defined as either a previous fetal or neonatal
-
Equivalence of single and standard doses of antenatal corticosteroids for late preterm neonatal outcomes: insights from a secondary analysis Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-07 Yossi Bart MD, Suneet P. Chauhan MD HonDSc, Michal Fishel Bartal MD, Sean Blackwell MD, Baha M. Sibai MD
The recent paradigm shift of treating individuals at risk of late preterm birth with antenatal corticosteroids warrants an assessment of the effect of single dosage. To compare outcomes of neonates born in the late preterm period (34.0–36.6 weeks) after a single dose of antenatal corticosteroids vs placebo. We performed a secondary analysis of the Antenatal Late Preterm Steroids trial. All individuals
-
Gestational diabetes mellitus is associated with in vivo platelet activation and platelet hyperreactivity Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-04 Giuseppe Guglielmini BSc PhD, Emanuela Falcinelli BSc PhD, Elisa Piselli BSc, Anna Maria Mezzasoma BSc, Francesca Tondi BSc, Luisa Alfonsi MD, Caterina De Luca MD, Valeria Fino MD, Alessandro Favilli MD, Sara Parrettini MD, Pietro Minuz MD, Elisabetta Torlone MD, Paolo Gresele MD PhD, Sandro Gerli MD
Gestational diabetes mellitus is associated with obstetrical and long-term cardiovascular complications. Although platelet hyperresponsiveness in type-2 diabetes mellitus has been well characterized and has been shown to play a crucial role in cardiovascular complications, this aspect has been little studied in gestational diabetes mellitus. We aimed to evaluate platelet reactivity, in vivo platelet
-
Chronic villitis as a distinctive feature of placental injury in maternal SARS-CoV-2 infection Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-03 Lauryn C. Gabby MD, Chelsea K. Jones MD, Brendan B. McIntyre MD, Zoe Manalo BS, Morgan Meads BS, Donald P. Pizzo PhD, Jessica Diaz-Vigil BS, Francesca Soncin PhD, Kathleen M. Fisch PhD, Gladys A. Ramos MD, Marni B. Jacobs PhD, Mana M. Parast MD PhD
SARS-CoV-2 infection during pregnancy is associated with an increased risk for stillbirth, preeclampsia, and preterm birth. However, this does not seem to be caused by intrauterine fetal infection because vertical transmission is rarely reported. There is a paucity of data regarding the associated placental SARS-CoV-2 histopathology and their relationship with the timing and severity of infection.
-
Umbilical artery eucapnic pH to assess fetal well-being Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-03 Thierry Daboval MD MSc FRCPC, Paul Ouellet PhD RRT FCCM, Amr El Shahed MD PhD DHPE, Linh Ly MD MEd, Caroline Ahearne MB PhD, Claude Racinet MD
Umbilical artery gas results help obstetricians assess fetal well-being during labor and guide screening decisions on eligibility for therapeutic hypothermia (ie, whole-body or head cooling). The accuracy of results, especially for the base deficit on arterial cord gas analysis, in predicting brain injury is questioned. A novel biomarker specifically calculated for fetal acid-base physiology and response
-
Magnesium sulfate and risk of hypoxic-ischemic encephalopathy in a high-risk cohort Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-03 Kathleen C. Minor MD, Jessica Liu PhD MPH, Maurice L. Druzin MD, Yasser Y. El-Sayed MD, Susan R. Hintz MD MSE, Sonia L. Bonifacio MD, Stephanie A. Leonard PhD, Henry C. Lee MD MS, Jochen Profit MD MPH, Scarlett D. Karakash MD
Hypoxic-ischemic encephalopathy contributes to morbidity and mortality among neonates ≥36 weeks of gestation. Evidence of preventative antenatal treatment is limited. Magnesium sulfate has neuroprotective properties among preterm fetuses. Hypertensive disorders of pregnancy are a risk factor for hypoxic-ischemic encephalopathy, and magnesium sulfate is recommended for maternal seizure prophylaxis among
-
Uterine isthmus contractions during pregnancy Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-01 Onur Yavuz MD, İbrahim Karaca MD
-
Uterine isthmus contractions: real-time ultrasound Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-04-01 Alba Farràs MD PhD, Nerea Maiz MD PhD, Elena Carreras MD PhD
-
Giant nabothian cysts mimicking genitourinary fistula Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-29 Daniel Lieberman MD, Catherine Seaman MD, Anna Romanova MD, Emile Gleeson MD, Lisa Dabney MD
-
Cervical atresia and an obliterated upper vagina presenting as primary amenorrhea Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-29 Rebecca J. Meiser MD, Toni S. Horton DO, Aakriti R. Carrubba MD, Sharif A. El Nashar MB BCh MS, Anita H. Chen MD
-
Cost-effectiveness analysis of expectant vs active management for treatment of persistent pregnancies of unknown location Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-27 Jessica R. Walter MD, Kurt T. Barnhart MD MSCE, Nathanael C. Koelper MPH, Nanette F. Santoro MD, Heping Zhang PhD, Tracey R. Thomas MPH, Hao Huang MD, Heidi S. Harvie MD MSCE MBA, Eunice Kennedy Shriver National Institute of Child Health and Human Development Reproductive Medicine Network
Persistent pregnancies of unknown location are defined by abnormally trending serum human chorionic gonadotropin with nondiagnostic ultrasound. There is no consensus on optimal management. This study aimed to assess the cost-effectiveness of 3 primary management strategies for persistent pregnancies of unknown location: (1) expectant management, (2) empirical 2-dose methotrexate, and (3) uterine evacuation
-
The association between postpartum depressive symptoms and contraception Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-27 Chloe N. Matovina MD MA, Allie Sakowicz MD MS, Emma C. Allen BS, Mayán I. Alvarado-Goldberg, Danielle Millan BA, Emily S. Miller MD MPH
Postpartum depression affects 10% to 20% of birthing people and is associated with changes in healthcare use. Little is known about the association between postpartum depressive symptoms and choice to use contraception; however, both untreated or undertreated depression and short interpregnancy intervals pose substantial perinatal health risks. This study aimed to evaluate whether postpartum depressive
-
Embryo long-term storage does not affect assisted reproductive technologies outcome: analysis of 58,001 vitrified blastocysts over 11 years Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-26 Ana Cobo PhD, Aila Coello PhD, María J. De Los Santos PhD, Jose Remohi MD, Jose Bellver MD
Recently, the potential detrimental effect that the duration of storage time may have on vitrified samples has raised some concerns, especially when some studies found an association between cryostorage length and decreased clinical results. This study aimed to evaluate the effects of the storage time length of day-5 vitrified blastocysts in 2 study groups: freeze-all cycles and nonelective frozen
-
Contribution of fetal blood sampling to determining the prognosis of congenital cytomegalovirus infections: a case-cohort study in Switzerland Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-26 Léo Pomar PhD, Agathe Contier MSc, Milos Stojanov PhD, Cécile Guenot MD, Joanna Sichitiu MD, Anita C. Truttmann MD, Yvan Vial MD, David Baud MD PhD
Cytomegalovirus is responsible for the most common congenital infection, affecting 0.5% to 1.0% of live births in Europe. Congenital cytomegalovirus infection can be diagnosed during pregnancy by viral DNA amplification in the amniotic fluid, but the prognosis of fetuses without severe brain abnormalities remains difficult to establish on the basis of prenatal imaging alone. To identify predictors
-
Prediction of metabolic syndrome following a first pregnancy Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-26 Tetsuya Kawakita MD MS, Philip Greenland MD, Victoria L. Pemberton RNC MS CCRC, William A. Grobman MD MBA, Robert M. Silver MD, C. Noel Bairey Merz MD, Rebecca B. McNeil PhD, David M. Haas MD MS, Uma M. Reddy MD MPH, Hyagriv Simhan MD, George R. Saade MD
The prevalence of metabolic syndrome is rapidly increasing in the United States. We hypothesized that prediction models using data obtained during pregnancy can accurately predict the future development of metabolic syndrome. This study aimed to develop machine learning models to predict the development of metabolic syndrome using factors ascertained in nulliparous pregnant individuals. This was a
-
Duration of biophysical profile in periviable and very preterm low-risk pregnancies Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-26 Luis M. Gomez MD MScE, Laura Willingham MD, Jenny Wang MD, Sebastian Nasrallah MD, Michael B. Vandillen MD, Giancarlo Mari MD MBA
In recent years, perinatal viability has shifted from 24 to 22 weeks of gestation at many institutions after improvements in survival in neonates delivered at the limit of viability. Monitoring these fetuses is essential because antenatal interventions with resuscitation efforts are available for patients at risk of delivery at the limit of viability. However, fetal monitoring using biophysical profiles
-
Enduring safety concerns for out-of-hospital births in the United States Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-26 Amos Grünebaum MD, Frank A. Chervenak MD
-
Cefazolin as the mainstay for antibiotic prophylaxis in patients with a penicillin allergy in obstetrics and gynecology Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-26 Karley J. Dutra MD, Gweneth B. Lazenby MD MSCR, Oluwatosin Goje MD MSCR, David E. Soper MD
Cefazolin is the most common antibiotic used for prophylaxis in obstetrics and gynecology. Among those with a penicillin allergy, alternative antibiotics are often chosen for prophylaxis, given fears of cross-reactivity between penicillin and cefazolin. Alternative antibiotics in this setting are associated with adverse sequelae, including surgical site infection, induction of bacterial resistance
-
Discrete glucose profiles identified using continuous glucose monitoring data and their association with adverse pregnancy outcomes Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-23 Ashley N. Battarbee MD MSCR, Sara M. Sauer PhD, Ayodeji Sanusi MD MPH, Isabel Fulcher PhD
Continuous glucose monitoring has facilitated the evaluation of dynamic changes in glucose throughout the day and their effect on fetal growth abnormalities in pregnancy. However, studies of multiple continuous glucose monitoring metrics combined and their association with other adverse pregnancy outcomes are limited. This study aimed to (1) use machine learning techniques to identify discrete glucose
-
Defining success after surgical treatment of stress urinary incontinence Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-23 Rubin Raju MD, Annetta M. Madsen MD, Brian J. Linder MD, John A. Occhino MD MS, John B. Gebhart MD MS, Michaela E. McGree BS, Amy L. Weaver MS, Emanuel C. Trabuco MD MS
A consensus standardized definition of success after stress urinary incontinence surgical treatment is lacking, which precludes comparisons between studies and affects patient counseling. This study aimed to identify optimal patient-centric definition(s) of success after stress urinary incontinence surgical treatment and to compare the identified “” treatment success definitions with a commonly used
-
The association between discordant umbilical arterial resistance in growth-restricted fetuses and adverse outcomes Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-23 Misgav Rottenstreich MBA MD, Swati Agrawal MD MSCR, Homero Flores Mendoza MD, Sarah D. McDonald MD, Bryon DeFrance MD, Jon F.R. Barrett MD PhD, Eran Ashwal MD
Assessing the umbilical artery pulsatility index via Doppler measurements plays a crucial role in evaluating fetal growth impairment. This study aimed to investigate perinatal outcomes associated with discordant pulsatility indices of umbilical arteries in fetuses with growth restriction. In this retrospective cohort study, all singleton pregnancies were included if their estimated fetal weight and/or
-
The effect of subsequent pregnancy and childbirth on stress urinary incontinence recurrence after midurethral sling procedure: a comment Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-23 Aisling A. Clancy MD MSc MPH, Jocelyn Stairs MD MPH
-
Magnesium sulfate prophylaxis for late-postpartum severe hypertension Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-23 Kristen Cagino MD, Malavika Prabhu MD, Baha Sibai MD
-
Duration of magnesium sulfate for late postpartum hypertension: is 24 hours always necessary? Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-23 Richard L. Fischer MD
-
The effect of subsequent pregnancy and childbirth on stress urinary incontinence recurrence after midurethral sling procedure: a response Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-23 Chen Nahshon MD, Yoram Abramov MD, Ariel Zilberlicht MD
-
The value of maternal echocardiography after delivery in patients with severe preeclampsia Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-23 Agata Kantorowska MD, Anthony Marco Corbo DO, Meredith B. Akerman MS, George Gubernikoff MD, Wendy L. Kinzler MD, Anthony M. Vintzileos MD, Patricia Rekawek MD
-
Cardiovascular protection by normotensive placental extracellular vesicles Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-22 Sandy Lau PhD, Yourong Feng MD PhD, Larry Chamley PhD, Carolyn Barrett PhD
-
Long-term cardiovascular protection by normotensive placental extracellular vesicles Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-22 Lionel Carbillon MD PhD
-
Reproductive and obstetrical outcomes after treatment of retained products of conception: hysteroscopic removal vs ultrasound-guided electric vacuum aspiration, a prospective follow-up study Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-21 Liselot P. Wagenaar MD, Wouter L.J. van Vugt MD, Aleida G. Huppelschoten MD PhD, Celine M. Radder MD PhD, Louisette W. Peters MD, Steven Weyers MD PhD, Steffi van Wessel MD PhD, Benedictus C. Schoot MD PhD, Tjalina W.O. Hamerlynck MD PhD, Huib A. van Vliet MD PhD
Traditionally, curettage has been the most widely performed surgical intervention for removing retained products of conception. However, hysteroscopic removal is increasingly performed as an alternative because of the potentially lower risk of intrauterine adhesions and higher rates of complete removal. Until recently, studies comparing curettage with hysteroscopic removal regarding reproductive and
-
Preoperative free access to water compared to fasting for planned cesarean under spinal anesthesia: a randomized controlled trial Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-21 Yee Ling Ng MObGyn, Sabeetha Segaran MObGyn, Carolyn Chue Wai Yim MMed (Anesthesia) Fellowship Obstetric Anesthesia, Boon Kiong Lim MRCOG, Mukhri Hamdan MObGyn PhD, Farah Gan MObGyn, Peng Chiong Tan FRCOG PhD
Contemporary guidance for preoperative feeding allows solids up to 6 hours and clear fluids up to 2 hours before anesthesia. Clinical trial evidence to support this approach for cesarean delivery is lacking. Many medical practitioners continue to follow conservative policies of no intake from midnight to the time of surgery, especially in pregnant women. This study aimed to evaluate the pragmatic approach
-
Transcatheter arterial embolization outperforms surgery in reducing blood transfusions for postpartum vulvovaginal hematoma Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-20 Tsukasa Takahashi MD, Hasumi Tomita MD PhD, Hirotaka Hamada MD PhD, Mari Tadakawa MD PhD, Noriyuki Iwama MD PhD, Masatoshi Saito MD PhD
Postpartum vulvovaginal hematoma is a complication of vaginal delivery that may progress to life-threatening conditions. However, the management of hematomas, including conservative therapy, surgery, and arterial embolization, is yet to be standardized. This study aimed to: (1) evaluate hematoma features that can be treated conservatively, and (2) determine whether surgery or transcatheter arterial
-
Fetal fraction in noninvasive prenatal testing and adverse pregnancy outcomes Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-18 Lawrence M. Prensky MS
-
Posttraumatic stress disorder 2 months after cesarean delivery: a multicenter prospective study Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-16 Alizée Froeliger MD MPH, Catherine Deneux-Tharaux MD PhD, Lola Loussert MD MPH, Hugo Madar MD MPH, Loïc Sentilhes MD PhD FRCOG, Tranexamic Acid for Preventing Postpartum Hemorrhage after Cesarean Delivery (TRAAP2) trial study group, Loïc Sentilhes MD PhD, Marie V. Senat MD PhD, Maëla Le Lous MD, Norbert Winer MD PhD, Patrick Rozenberg MD PhD, Gilles Kayem MD PhD, Eric Verspyck MD PhD, Florent Fuchs
The prevalence and risk factors of posttraumatic stress disorder after cesarean delivery, outside high-risk contexts, remain unclear. This study aimed to assess posttraumatic stress disorder prevalence and risk factors at 2 months postpartum among a general population of women with cesarean delivery. This was a prospective ancillary cohort study of the Tranexamic Acid for Preventing Postpartum Hemorrhage
-
Systemic lupus erythematosus is associated with an increased frequency of spontaneous preterm births: systematic review and meta-analysis Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-16 Carolien N.H. Abheiden MD, Birgit S. Blomjous MD, Ciska Slaager MD, Anadeijda J.E.M.C. Landman MD, Johannes C.F. Ket MD, Jane E. Salmon PhD, Jill P. Buyon PhD, Martijn W. Heymans MD, Johanna I.P. de Vries MD PhD, Irene E.M. Bultink MD, Marjon A. de Boer MD
Preterm birth is one of the most frequent complications of pregnancy in women with systemic lupus erythematosus. The high indicated preterm birth proportion due to hypertensive disorders of pregnancy and/or fetal growth restriction is well known, and preventive measures and screening for early detection are performed. The risk of spontaneous preterm birth is less well recognized. This study aimed to
-
Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-15 Ane Cecilie Westerberg PhD, Maren-Helene Langeland Degnes PhD, Ina Jungersen Andresen PhD, Marie Cecilie Paasche Roland MD PhD, Trond Melbye Michelsen MD PhD
-
Fetal fraction in noninvasive prenatal testing and adverse pregnancy outcomes: a response Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-15 Ellis C. Becking MSc, Erik A. Sistermans PhD, Mireille N. Bekker PhD
-
Vasa previa in singleton pregnancies: diagnosis and clinical management based on an international expert consensus Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-15 Yinka Oyelese MD, Ali Javinani MD, Brittany Gudanowski BSc, Eyal Krispin MD, Andrei Rebarber MD, Ranjit Akolekar MD MRCOG PhD, Val Catanzarite MD PhD, Rohan D’Souza MD PhD FRCOG, Richard Bronsteen MD, Anthony Odibo MD MSCE, Matthias A. Scheier MD MSc, Junichi Hasegawa MD PhD, Eric Jauniaux MD PhD FRCOG Dr(hc), Christoph Lees MD, Deepa Srinivasan MBBS DGO MD MRCOG, Elizabeth Daly-Jones MSc, Gregory
-
The simultaneous occurrence of gestational diabetes and hypertensive disorders of pregnancy affects fetal growth and neonatal morbidity Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-14 Chioma Onuoha BA, Carolin C.M. Schulte PhD, Tanayott Thaweethai PhD, Sarah Hsu MS, Deepti Pant MPH, Kaitlyn E. James PhD, Sarbattama Sen MD, Anjali Kaimal MD MAS, Camille E. Powe MD
Gestational diabetes is associated with increased risk of hypertensive disorders of pregnancy, but there are limited data on fetal growth and neonatal outcomes when both conditions are present. We evaluated the risk of abnormal fetal growth and neonatal morbidity in pregnancies with co-occurrence of gestational diabetes and hypertensive disorders of pregnancy. In a retrospective study of 47,093 singleton
-
Maternal mortality in the United States: are the high and rising rates due to changes in obstetrical factors, maternal medical conditions, or maternal mortality surveillance? Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-12 K.S. Joseph MD PhD, Sarka Lisonkova MD PhD, Amélie Boutin MSc PhD, Giulia M. Muraca MPH PhD, Neda Razaz MPH PhD, Sid John MSc, Yasser Sabr MHSc MD, Wee-Shian Chan MSc MD, Azar Mehrabadi MSc PhD, Justin S. Brandt MD, Enrique F. Schisterman PhD, Cande V. Ananth PhD MPH
National Vital Statistics System reports show that maternal mortality rates in the United States have nearly doubled, from 17.4 in 2018 to 32.9 per 100,000 live births in 2021. However, these high and rising rates could reflect issues unrelated to obstetrical factors, such as changes in maternal medical conditions or maternal mortality surveillance (eg, due to introduction of the pregnancy checkbox)
-
A new technique to preserve the uterus in placenta accreta spectrum: a reply Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-09 Sergey Barinov MD PhD, Gian Carlo Di Renzo PhD
-
A new technique to preserve the uterus in placenta accreta spectrum Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-09 Baihui Zhao MD, Jiamin Chen MM, Qiong Luo PhD
-
Pregnancies complicated by bulimia nervosa are at increased risk of chorioamnionitis, anemia, and preterm birth Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-08 Rebecca J. Baer MPH, Gretchen Bandoli PhD, Laura L. Jelliffe-Pawlowski PhD, Kyung E. Rhee MD MSc MA, Christina D. Chambers PhD MPH
-
Plasma proteins and persistent postsurgical pelvic pain among adolescents and young adults with endometriosis Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-08 Naoko Sasamoto MD PhD, Long Ngo PhD, Allison F. Vitonis ScM, Simon T. Dillon PhD, Pooja Prasad BS, Marc R. Laufer MD, Sawsan As-Sanie MD MPH, Andrew Schrepf PhD, Stacey A. Missmer ScD, Towia A. Libermann PhD, Kathryn L. Terry ScD
Noninvasive biomarkers that predict surgical treatment response would inform personalized treatments and provide insight into potential biologic pathways underlying endometriosis-associated pain and symptom progression. To use plasma proteins in relation to the persistence of pelvic pain following laparoscopic surgery in predominantly adolescents and young adults with endometriosis using a multiplex
-
Lichen planus follicularis tumidus of the vulva Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-08 Denali E. Termin, Kathryn C. Welch MD, Hope K. Haefner MD, Lynette J. Margesson MD, Maxwell D. Wang MD, Natalie A. Saunders MD, Ebony C. Parker-Featherstone MD
-
Parturition at term: induction, second and third stages of labor, and optimal management of life-threatening complications—hemorrhage, infection, and uterine rupture Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-08 Roberto Romero MD DMedSci, Virginia Sabo Romero RN MSN, Karim D. Kalache MD PhD, Joanne Stone MD MS
-
Training for intrapartum sonography using optical ultrasound simulation Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-08 Anna E. Clark MBBS, Neysa Patel BSc, Mariya Kovalenko MBBS, Arwa Hanidu MSc, Sana Usman MBBS MRCOG PhD, Christoph Lees MD FRCOG
-
A randomized trial of double vs single-dose etonogestrel implant to overcome the interaction with efavirenz-based antiretroviral therapy Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-07 Catherine A. Chappell MD MSc, Mohammed Lamorde FRCP PhD, Shadia Nakalema MBChB, Isabella Kyohairwe BRH MSc, Pauline Byakika-Kibwika MBChB MMed MSc PhD FPCPE, Leslie A. Meyn PhD, Michelle M. Pham PhD MS, Kimberly K. Scarsi PharmD MSc
Concomitant use of efavirenz-based antiretroviral therapy and a standard-dose etonogestrel contraceptive implant led to 82% lower etonogestrel exposure when compared with women who do not receive antiretroviral therapy. The clinical impact of this reduced exposure is supported by retrospective cohort evaluations that demonstrated higher rates of unintended pregnancies when contraceptive implants were
-
Racial and ethnic differences in early death among gynecologic malignancy Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-07 Matthew W. Lee MD, Andrew Vallejo MD MS, Katelyn B. Furey MD, Sabrina M. Woll BA, Maximilian Klar MD MPH, Lynda D. Roman MD, Jason D. Wright MD, Koji Matsuo MD PhD
Racial and ethnic differences in early death after cancer diagnosis have not been well studied in gynecologic malignancy. This study aimed to assess population-level trends and characteristics of early death among patients with gynecologic malignancy based on race and ethnicity in the United States. The National Cancer Institute’s Surveillance, Epidemiology, and End Results Program was queried to examine
-
Birthweights at term have increased globally: insights from a systematic review of 183 million births Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-07 Giulia Bonanni MD, Chiara Airoldi PhD, Vincenzo Berghella MD
-
Metformin in pregnancy and childhood neurodevelopmental outcomes: a systematic review and meta-analysis Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-07 Hannah G. Gordon MD, Jessica A. Atkinson BBiomedSc (Hons), Stephen Tong PhD, Parinaz Mehdipour PhD, Catherine Cluver PhD, Susan P. Walker MD, Anthea C. Lindquist DPhil, Roxanne M. Hastie PhD
-
Added value of intrapartum recording of the maternal heart rate as an adjunct to fetal monitoring using external ultrasound transducer: not only about artifacts Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-06 Andrea Dall’Asta PhD, Lavinia Volpi MD, Giovanni Morganelli MD, Tullio Ghi PhD
-
Sexual orientation disparities in adverse pregnancy outcomes Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-06 Payal Chakraborty PhD, Ellis Schroeder, Colleen A. Reynolds MS, Sarah McKetta MD PhD, Juno Obedin-Maliver MD, S. Bryn Austin ScD, Bethany Everett PhD, Sebastien Haneuse PhD, Brittany M. Charlton ScD
-
Hysterotomy closure at cesarean, beyond the number of layers; a response Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-06 Carry Verberkt MD, Sanne I. Stegwee PhD, Judith A.F. Huirne MD PhD
-
Maternal heart rate decelerations in cardiotocography as a warning sign of uterine rupture Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-06 Mikko Tarvonen RNM MSc, Vedran Stefanovic MD PhD, Sture Andersson MD PhD
-
Hysterotomy closure at cesarean: beyond the number of layers Am. J. Obstet. Gynecol. (IF 9.8) Pub Date : 2024-03-06 Sarah Maheux-Lacroix MD PhD, Emmanuel Bujold MD MSc